| Year |
Citation |
Score |
| 2020 |
Singh AK, Kapoor V, Thotala D, Hallahan DE. TAF15 contributes to the radiation-inducible stress response in cancer. Oncotarget. 11: 2647-2659. PMID 32676166 DOI: 10.18632/oncotarget.27663 |
0.371 |
|
| 2019 |
Hallahan D. ATM Inhibition Sensitizes Tumors to High-Dose Irradiation. Cancer Research. 79: 704-705. PMID 30770366 DOI: 10.1158/0008-5472.Can-18-4072 |
0.408 |
|
| 2019 |
Campian JL, Kapoor V, Griffith K, Mahadevan A, Collins A, Thotala S, Jash A, Hu T, Lee BH, Choi D, Yang SH, Hallahan D, Chheda MG, Thotala D. Effect of a novel long-acting interleukin-7 agonist, NT-I7, on survival in mouse models of glioma. Journal of Clinical Oncology. 37: e13516-e13516. DOI: 10.1200/Jco.2019.37.15_Suppl.E13516 |
0.335 |
|
| 2019 |
Kapoor V, Singh AK, Thotala D, Hallahan D. Abstract 2389: Role of Midkine in molecular targeted therapy to TIP1 for lung cancer treatment Cancer Research. 79: 2389-2389. DOI: 10.1158/1538-7445.Am2019-2389 |
0.387 |
|
| 2019 |
Singh A, Kapoor V, Diebolder P, Rhee A, Rogers B, Thotala D, Hallahan D. Abstract 2377: Development and characterization of scFvs against TIP1/PDZ protein for cancer targeting Cancer Research. 79: 2377-2377. DOI: 10.1158/1538-7445.Am2019-2377 |
0.367 |
|
| 2018 |
Lin AJ, Rao YJ, Chin RI, Campian J, Mullen D, Thotala D, Daly M, Gay H, Oppelt P, Hallahan D, Adkins D, Thorstad W. Post-operative radiation effects on lymphopenia, neutrophil to lymphocyte ratio, and clinical outcomes in palatine tonsil cancers. Oral Oncology. 86: 1-7. PMID 30409288 DOI: 10.1016/J.Oraloncology.2018.08.008 |
0.369 |
|
| 2018 |
Yuan J, Zhang F, Hallahan D, Zhang Z, He L, Wu LG, You M, Yang Q. Reprogramming glioblastoma multiforme cells into neurons by protein kinase inhibitors. Journal of Experimental & Clinical Cancer Research : Cr. 37: 181. PMID 30071868 DOI: 10.1186/S13046-018-0857-5 |
0.396 |
|
| 2018 |
Dadey DY, Kapoor V, Khudanyan A, Thotala D, Hallahan DE. PERK Regulates Glioblastoma Sensitivity to ER Stress While Promoting Radiation Resistance. Molecular Cancer Research : McR. PMID 29991528 DOI: 10.1158/1541-7786.MCR-18-0224 |
0.31 |
|
| 2018 |
Rudra S, Hui C, Rao YJ, Samson P, Lin AJ, Chang X, Tsien C, Fergus S, Mullen D, Yang D, Thotala D, Hallahan D, Campian JL, Huang J. Effect of Radiation Treatment Volume Reduction on Lymphopenia in Patients Receiving Chemoradiotherapy for Glioblastoma. International Journal of Radiation Oncology, Biology, Physics. PMID 29502931 DOI: 10.1016/J.Ijrobp.2018.01.069 |
0.346 |
|
| 2018 |
Kapoor V, Singh AK, Dadey D, Hoye K, Collins A, Thotala D, Hallahan D. Abstract 5615: Antibodies targeting TIP1 enhance the efficacy of radiotherapy in lung cancer and glioblastoma Cancer Research. 78: 5615-5615. DOI: 10.1158/1538-7445.Am2018-5615 |
0.408 |
|
| 2018 |
Singh A, Kapoor V, Dadey D, Thotala D, Hallahan D. Abstract 5614: Targeting the radiation-inducible neoantigen GRP78 as a novel strategy for non-small cell lung carcinoma treatment Cancer Research. 78: 5614-5614. DOI: 10.1158/1538-7445.Am2018-5614 |
0.407 |
|
| 2017 |
Cuculich PS, Schill MR, Kashani R, Mutic S, Lang A, Cooper D, Faddis M, Gleva M, Noheria A, Smith TW, Hallahan D, Rudy Y, Robinson CG. Noninvasive Cardiac Radiation for Ablation of Ventricular Tachycardia. The New England Journal of Medicine. 377: 2325-2336. PMID 29236642 DOI: 10.1056/Nejmoa1613773 |
0.318 |
|
| 2017 |
Kapoor V, Dadey D, Hoye K, Collins A, Thotala D, Hallahan D. Abstract 4599: Antibody targeting PDZ domain of TIP-1 induces proliferation arrest through AKT/mTOR signaling inhibition in lung cancer and glioblastoma Cancer Research. 77: 4599-4599. DOI: 10.1158/1538-7445.Am2017-4599 |
0.413 |
|
| 2016 |
Dadey DY, Kapoor V, Hoye K, Khudanyan A, Collins A, Thotala D, Hallahan DE. Antibody targeting GRP78 enhances the efficacy of radiation therapy in human glioblastoma and non-small-cell lung cancer cell lines and tumor models. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27815359 DOI: 10.1158/1078-0432.CCR-16-1935 |
0.311 |
|
| 2016 |
Kaliberov SA, Kaliberova LN, Yan H, Kapoor V, Hallahan DE. Retargeted adenoviruses for radiation-guided gene delivery. Cancer Gene Therapy. PMID 27492853 DOI: 10.1038/Cgt.2016.32 |
0.43 |
|
| 2016 |
Kapoor V, Dadey D, Nguyen K, Li H, Rogers B, Thotala D, Hallahan D. Abstract 4202: Peptide probes binding to radiation-inducible cell surface GRP78 as a novel targeting strategy for various tumors Cancer Research. 76: 4202-4202. DOI: 10.1158/1538-7445.Am2016-4202 |
0.495 |
|
| 2016 |
Dadey D, Kapoor V, Thotala D, Hallahan D. PO-0985: Anti-GRP 78 antibodies bind specifically to cancers enhance efficacy of radiotherapy in cancer Radiotherapy and Oncology. 119: S478-S479. DOI: 10.1016/S0167-8140(16)32235-6 |
0.31 |
|
| 2016 |
Hallahan D, Kapoor V, Thotala D, Yan H. PO-0981: Activation of immune cells and enhanced efficacy of radiotherapy by anti-TIP1 antibodies in cancer Radiotherapy and Oncology. 119: S477. DOI: 10.1016/S0167-8140(16)32231-9 |
0.305 |
|
| 2015 |
Thotala D, Karvas RM, Engelbach JA, Garbow JR, Hallahan AN, DeWees TA, Laszlo A, Hallahan DE. Valproic acid enhances the efficacy of radiation therapy by protecting normal hippocampal neurons and sensitizing malignant glioblastoma cells. Oncotarget. PMID 26413814 DOI: 10.18632/Oncotarget.5253 |
0.366 |
|
| 2015 |
Zhao DY, Jacobs KM, Hallahan DE, Thotala D. Silencing Egr1 Attenuates Radiation-Induced Apoptosis in Normal Tissues while Killing Cancer Cells and Delaying Tumor Growth. Molecular Cancer Therapeutics. PMID 26206332 DOI: 10.1158/1535-7163.MCT-14-1051 |
0.35 |
|
| 2015 |
Thotala D, Karvas RM, Engelbach JA, Garbow JR, Hallahan AN, DeWees TA, Laszlo A, Hallahan DE. Valproic acid enhances the efficacy of radiation therapy by protecting normal hippocampal neurons and sensitizing malignant glioblastoma cells Oncotarget. 6: 35004-35022. DOI: 10.18632/oncotarget.5253 |
0.366 |
|
| 2015 |
Muhoro L, Yan H, Kaliberov S, Jaboin J, Curiel D, Hallahan D. Abstract 4376: Characterization and targeting of TAF15, a radiation-inducible target in multiple cancer types Cancer Research. 75: 4376-4376. DOI: 10.1158/1538-7445.Am2015-4376 |
0.45 |
|
| 2015 |
Yan H, Nguyen K, Kapoor V, Mnich S, Scott J, Li H, Rogers B, Thotala D, Hallahan D. Abstract 4368: Targeting of a radiation inducible tax-interaction protein 1 (Tip 1) as a novel molecule for cancer treatment Cancer Research. 75: 4368-4368. DOI: 10.1158/1538-7445.Am2015-4368 |
0.404 |
|
| 2015 |
Khudanyan A, Dadey D, Karvas R, Kotipatruni R, Hallahan D, Thotala D. Abstract 3326: Targeting lysophosphatidic acid receptor 1 (LPAR1) radiosensitizes poor prognosis cancers Cancer Research. 75: 3326-3326. DOI: 10.1158/1538-7445.Am2015-3326 |
0.47 |
|
| 2015 |
Dadey D, Kapoor V, Khudanyan A, Thotala D, Hallahan D. Abstract 3323: Radiation-induced ER stress contributes to survival in glioblastoma cell lines Cancer Research. 75: 3323-3323. DOI: 10.1158/1538-7445.Am2015-3323 |
0.477 |
|
| 2015 |
Kapoor V, Dadey D, Nguyen K, Li H, Rogers B, Thotala D, Hallahan D. Abstract 1791: Targeting radiation-inducible cell surface GRP78 using GIRLRG peptide as a novel imaging and therapeutic strategy for tumors Cancer Research. 75: 1791-1791. DOI: 10.1158/1538-7445.Am2015-1791 |
0.471 |
|
| 2014 |
Wang H, Han M, Whetsell W, Wang J, Rich J, Hallahan D, Han Z. Tax-interacting protein 1 coordinates the spatiotemporal activation of Rho GTPases and regulates the infiltrative growth of human glioblastoma. Oncogene. 33: 1558-69. PMID 23563176 DOI: 10.1038/Onc.2013.97 |
0.313 |
|
| 2014 |
Dadey DYA, Karvas RM, Kotipatruni R, Jaboin J, Hallahan D, Thotala D. Abstract 846: Inhibition of lysophosphatidic acid receptor 1 radiosensitizes lung cancer cells Cancer Research. 74: 846-846. DOI: 10.1158/1538-7445.Am2014-846 |
0.478 |
|
| 2014 |
Muhoro L, Yan H, Hunn J, Thotala D, Ferraro D, Hallahan D. Abstract 4597: Characterization and targeting of radiation-inducible neoantigens in multiple cancer types Cancer Research. 74: 4597-4597. DOI: 10.1158/1538-7445.Am2014-4597 |
0.453 |
|
| 2014 |
Kapoor V, Nguyen K, Yan H, Li H, Rogers B, Thotala D, Hallahan D. Monoclonal Antibody 2C6F3 Against Radiation-Inducible Cell Surface Tip-1 as a Novel Agent for Imaging and Targeting Tumors International Journal of Radiation Oncology*Biology*Physics. 90: S794. DOI: 10.1016/J.Ijrobp.2014.05.2294 |
0.408 |
|
| 2014 |
Dadet D, Khudanyan A, Thotala D, Hallahan D. Inhibition of the PERK Arm of the Endoplasmic Reticulum Stress Response Attenuates VEGF Production in Irradiated Glioblastoma Cell Lines International Journal of Radiation Oncology*Biology*Physics. 90: S774. DOI: 10.1016/J.Ijrobp.2014.05.2241 |
0.306 |
|
| 2013 |
Bhave SR, Dadey DY, Karvas RM, Ferraro DJ, Kotipatruni RP, Jaboin JJ, Hallahan AN, Dewees TA, Linkous AG, Hallahan DE, Thotala D. Autotaxin Inhibition with PF-8380 Enhances the Radiosensitivity of Human and Murine Glioblastoma Cell Lines. Frontiers in Oncology. 3: 236. PMID 24062988 DOI: 10.3389/Fonc.2013.00236 |
0.741 |
|
| 2013 |
Thotala D, Craft JM, Ferraro DJ, Kotipatruni RP, Bhave SR, Jaboin JJ, Hallahan DE. Cytosolic phospholipaseA2 inhibition with PLA-695 radiosensitizes tumors in lung cancer animal models. Plos One. 8: e69688. PMID 23894523 DOI: 10.1371/journal.pone.0069688 |
0.41 |
|
| 2013 |
Laszlo A, Thotala D, Hallahan DE. Membrane phospholipids, EML4-ALK, and Hsp90 as novel targets in lung cancer treatment. Cancer Journal (Sudbury, Mass.). 19: 238-46. PMID 23708071 DOI: 10.1097/PPO.0b013e31829a68eb |
0.367 |
|
| 2012 |
Kotipatruni RP, Ferraro DJ, Ren X, Vanderwaal RP, Thotala DK, Hallahan DE, Jaboin JJ. NDRG4, the N-Myc downstream regulated gene, is important for cell survival, tumor invasion and angiogenesis in meningiomas. Integrative Biology : Quantitative Biosciences From Nano to Macro. 4: 1185-97. PMID 22869042 DOI: 10.1039/c2ib20168b |
0.309 |
|
| 2012 |
Sweeney K, Bhave S, Hu R, Fong J, Hallahan D, Thotala DK. Abstract 1457: Valproic acid enhances radiation therapy by protecting normal hippocampal neurons and sensitizing malignant glioblastoma cells Cancer Research. 72: 1457-1457. DOI: 10.1158/1538-7445.Am2012-1457 |
0.445 |
|
| 2012 |
Yan H, Varki V, Fu A, Hallahan D. Targeting of Radiation Inducible Antigen on Human Lung Cancer Cells International Journal of Radiation Oncology*Biology*Physics. 84: S128. DOI: 10.1016/J.Ijrobp.2012.07.133 |
0.422 |
|
| 2011 |
Schleicher SM, Thotala DK, Linkous AG, Hu R, Leahy KM, Yazlovitskaya EM, Hallahan DE. Autotaxin and LPA receptors represent potential molecular targets for the radiosensitization of murine glioma through effects on tumor vasculature. Plos One. 6: e22182. PMID 21799791 DOI: 10.1371/Journal.Pone.0022182 |
0.756 |
|
| 2011 |
Craft JM, Hallahan D. Towards novel radiosensitizing agents: the role of cytosolic PLA2α in combined modality cancer therapy. Future Medicinal Chemistry. 3: 835-43. PMID 21644828 DOI: 10.4155/Fmc.11.38 |
0.518 |
|
| 2011 |
Schulte RR, Linkous AG, Hallahan DE, Yazlovitskaya EM. Cytosolic phospholipase A2 as a molecular target for the radiosensitization of ovarian cancer. Cancer Letters. 304: 137-43. PMID 21397389 DOI: 10.1016/J.Canlet.2011.02.015 |
0.77 |
|
| 2011 |
Dickey A, Schleicher S, Leahy K, Hu R, Hallahan D, Thotala DK. GSK-3β inhibition promotes cell death, apoptosis, and in vivo tumor growth delay in neuroblastoma Neuro-2A cell line. Journal of Neuro-Oncology. 104: 145-53. PMID 21161565 DOI: 10.1007/S11060-010-0491-3 |
0.384 |
|
| 2011 |
Ferraro D, Hallahan D. WE-A-BRB-03: X-Ray Guided Targeting of Nanoparticles to Cancer Medical Physics. 38: 3792-3792. DOI: 10.1118/1.3613270 |
0.342 |
|
| 2011 |
Thotala D, Garbow J, Drzymala R, Hallahan D. TU-G-214-01: Imaging of Necrosis and PET Imaging Medical Physics. 38: 3783-3783. DOI: 10.1118/1.3613239 |
0.386 |
|
| 2011 |
Garbow J, Thotala D, Drzymala R, Hallahan D. TU-A-BRC-05: Imaging to Monitor the Efficacy of Novel Molecular Targeted Radiation Protecting Drugs Medical Physics. 38: 3742-3742. DOI: 10.1118/1.3613081 |
0.381 |
|
| 2011 |
Thotala D, Sweeney K, Leahy K, Hu R, Hallahan D. Valproic Acid Enhances Radiation Therapy by Protecting Normal Hippocampal Neurons and Sensitizing Malignant Glioblastoma Cells In Vivo and In Vitro International Journal of Radiation Oncology*Biology*Physics. 81: S669. DOI: 10.1016/J.Ijrobp.2011.06.919 |
0.372 |
|
| 2011 |
Craft J, Thotala D, Hu R, Leahy K, Hallahan D. Cytosolic PhospholipaseA2 (cPLA2) Inhibition with Girapladib Radiosensitizes Endothelium and is Effective in Non-small Cell Lung Cancer (NSCLC) Animal Models International Journal of Radiation Oncology*Biology*Physics. 81: S86. DOI: 10.1016/J.Ijrobp.2011.06.175 |
0.321 |
|
| 2011 |
Hallahan D. Antibodies Targeted to Radiation Inducible Neoantigens in Cancer International Journal of Radiation Oncology*Biology*Physics. 81: S751. DOI: 10.1016/j.ijrobp.2011.06.1245 |
0.31 |
|
| 2010 |
Linkous AG, Yazlovitskaya EM, Hallahan DE. Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis. Journal of the National Cancer Institute. 102: 1398-412. PMID 20729478 DOI: 10.1093/Jnci/Djq290 |
0.742 |
|
| 2010 |
Wang H, Yan H, Fu A, Han M, Hallahan D, Han Z. TIP-1 translocation onto the cell plasma membrane is a molecular biomarker of tumor response to ionizing radiation. Plos One. 5: e12051. PMID 20711449 DOI: 10.1371/Journal.Pone.0012051 |
0.404 |
|
| 2010 |
Wang H, Hallahan D, Han Z. Abstract 417: Tax-interacting protein 1 (TIP-1) as one biomarker of invasive astrocytomas Cancer Research. 70: 417-417. DOI: 10.1158/1538-7445.Am10-417 |
0.394 |
|
| 2009 |
Thotala D, Chetyrkin S, Hudson B, Hallahan D, Voziyan P, Yazlovitskaya E. Pyridoxamine protects intestinal epithelium from ionizing radiation-induced apoptosis. Free Radical Biology & Medicine. 47: 779-85. PMID 19540915 DOI: 10.1016/J.Freeradbiomed.2009.06.020 |
0.353 |
|
| 2009 |
Linkous A, Geng L, Lyshchik A, Hallahan DE, Yazlovitskaya EM. Cytosolic phospholipase A2: targeting cancer through the tumor vasculature. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 1635-44. PMID 19240173 DOI: 10.1158/1078-0432.Ccr-08-1905 |
0.779 |
|
| 2008 |
Loveless ME, Li X, Huamani J, Lyshchik A, Dawant B, Hallahan D, Gore JC, Yankeelov TE. A method for assessing the microvasculature in a murine tumor model using contrast-enhanced ultrasonography. Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine. 27: 1699-709. PMID 19022995 DOI: 10.7863/Jum.2008.27.12.1699 |
0.319 |
|
| 2008 |
Yazlovitskaya EM, Linkous AG, Thotala DK, Cuneo KC, Hallahan DE. Cytosolic phospholipase A2 regulates viability of irradiated vascular endothelium. Cell Death and Differentiation. 15: 1641-53. PMID 18566601 DOI: 10.1038/Cdd.2008.93 |
0.738 |
|
| 2008 |
Cuneo KC, Geng L, Fu A, Orton D, Hallahan DE, Chakravarthy AB. SU11248 (sunitinib) sensitizes pancreatic cancer to the cytotoxic effects of ionizing radiation. International Journal of Radiation Oncology, Biology, Physics. 71: 873-9. PMID 18514780 DOI: 10.1016/j.ijrobp.2008.02.062 |
0.315 |
|
| 2008 |
Tu T, Thotala D, Geng L, Hallahan DE, Willey CD. Bone marrow X kinase-mediated signal transduction in irradiated vascular endothelium. Cancer Research. 68: 2861-9. PMID 18413754 DOI: 10.1158/0008-5472.Can-07-5743 |
0.387 |
|
| 2008 |
Hariri G, Zhang Y, Fu A, Han Z, Brechbiel M, Tantawy MN, Peterson TE, Mernaugh R, Hallahan D. Radiation-guided P-selectin antibody targeted to lung cancer. Annals of Biomedical Engineering. 36: 821-30. PMID 18273706 DOI: 10.1007/S10439-008-9444-9 |
0.389 |
|
| 2008 |
Thotala D, Hallahan D, Yazlovitskaya EM. Inhibition of glycogen synthase kinase 3β attenuates neurocognitive dysfunction resulting from cranial irradiation (Cancer Research (2008) 68, (5859-5868)) Cancer Research. 68. DOI: 10.1158/0008-5472.Can-68-19-Cor2 |
0.314 |
|
| 2008 |
Linkous A, Geng L, Hallahan D, Yazlovitskaya E. Cytosolic Phospholipase a2 (cpla2): Targeting Cancer Through the Ablation of Tumor Vasculature International Journal of Radiation Oncology*Biology*Physics. 72: S64. DOI: 10.1016/J.Ijrobp.2008.06.909 |
0.754 |
|
| 2007 |
Cuneo KC, Fu A, Osusky K, Huamani J, Hallahan DE, Geng L. Histone deacetylase inhibitor NVP-LAQ824 sensitizes human nonsmall cell lung cancer to the cytotoxic effects of ionizing radiation. Anti-Cancer Drugs. 18: 793-800. PMID 17581301 DOI: 10.1097/CAD.0b013e3280b10d57 |
0.356 |
|
| 2007 |
Cuneo KC, Tu T, Geng L, Fu A, Hallahan DE, Willey CD. HIV protease inhibitors enhance the efficacy of irradiation. Cancer Research. 67: 4886-93. PMID 17510418 DOI: 10.1158/0008-5472.Can-06-3684 |
0.358 |
|
| 2007 |
Hariri G, Croce T, Harth E, Han Z, Tantawy N, Peterson T, Baldwin R, Hallahan D. Radiation Guided Peptide Targeting to Tumor Microvasculature using Nanoparticle Carriers International Journal of Radiation Oncology*Biology*Physics. 69: S151-S152. DOI: 10.1016/J.Ijrobp.2007.07.276 |
0.385 |
|
| 2007 |
Linkous A, Cuneo K, Hallahan D, Yazlovitskaya E. Cytosolic Phospholipase A2-Dependent Signaling Protects Normal Cells From Radiation-Induced Cytotoxicity International Journal of Radiation Oncology*Biology*Physics. 69: S127. DOI: 10.1016/J.Ijrobp.2007.07.236 |
0.751 |
|
| 2007 |
Jaboin J, Fu A, Hariri G, Han Z, Hallahan D. Novel Radiation-Guided Nanoparticle Drug Delivery System for Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 69: S111. DOI: 10.1016/J.Ijrobp.2007.07.204 |
0.319 |
|
| 2007 |
Wang H, Fu A, Han Z, Hallahan D. Tax Interacting Protein (TIP-1): A Potential Radiation Inducible Receptor Within Cancer International Journal of Radiation Oncology*Biology*Physics. 69: S590-S591. DOI: 10.1016/J.Ijrobp.2007.07.1886 |
0.371 |
|
| 2006 |
Kim DW, Huamani J, Niermann KJ, Lee H, Geng L, Leavitt LL, Baheza RA, Jones CC, Tumkur S, Yankeelov TE, Fleischer AC, Hallahan DE. Noninvasive assessment of tumor vasculature response to radiation-mediated, vasculature-targeted therapy using quantified power Doppler sonography: implications for improvement of therapy schedules. Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine. 25: 1507-17. PMID 17121945 DOI: 10.7863/Jum.2006.25.12.1507 |
0.351 |
|
| 2006 |
Kim KW, Mutter RW, Cao C, Albert JM, Freeman M, Hallahan DE, Lu B. Autophagy for cancer therapy through inhibition of pro-apoptotic proteins and mammalian target of rapamycin signaling. The Journal of Biological Chemistry. 281: 36883-90. PMID 17005556 DOI: 10.1074/jbc.M607094200 |
0.32 |
|
| 2006 |
Han Z, Wang H, Hallahan DE. Radiation-guided gene therapy of cancer. Technology in Cancer Research & Treatment. 5: 437-44. PMID 16866574 |
0.324 |
|
| 2006 |
Kim DW, Huamani J, Fu A, Hallahan DE. Molecular strategies targeting the host component of cancer to enhance tumor response to radiation therapy. International Journal of Radiation Oncology, Biology, Physics. 64: 38-46. PMID 16377414 DOI: 10.1016/j.ijrobp.2005.02.008 |
0.403 |
|
| 2006 |
Geng L, Shinohara ET, Kim D, Tan J, Osusky K, Shyr Y, Hallahan DE. STI571 (Gleevec) improves tumor growth delay and survival in irradiated mouse models of glioblastoma. International Journal of Radiation Oncology, Biology, Physics. 64: 263-71. PMID 16274936 DOI: 10.1016/j.ijrobp.2005.08.025 |
0.331 |
|
| 2006 |
Yazlovitskaya E, Cuneo K, Linkous A, Hallahan D. 2602 International Journal of Radiation Oncology*Biology*Physics. 66: S544-S545. DOI: 10.1016/J.Ijrobp.2006.07.1016 |
0.689 |
|
| 2005 |
Duggan D, Murphy BA, Beach M, Teng M, Hallahan D, Burkey B, Netterville J, Chung CH, Butler L, Cmelak AJ. Intensity-modulated radiation therapy (IMRT) with concurrent taxane-based chemotherapy for locally-advanced head and neck cancer(LAHNC): Feasibility, technique, and toxicities. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 5536. PMID 27945260 DOI: 10.1200/Jco.2005.23.16_Suppl.5536 |
0.406 |
|
| 2005 |
Lu B, Shinohara ET, Edwards E, Geng L, Tan J, Hallahan DE. The use of tyrosine kinase inhibitors in modifying the response of tumor microvasculature to radiotherapy. Technology in Cancer Research & Treatment. 4: 691-8. PMID 16292890 |
0.348 |
|
| 2005 |
Abdollahi A, Griggs DW, Zieher H, Roth A, Lipson KE, Saffrich R, Gröne HJ, Hallahan DE, Reisfeld RA, Debus J, Niethammer AG, Huber PE. Inhibition of alpha(v)beta3 integrin survival signaling enhances antiangiogenic and antitumor effects of radiotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 6270-9. PMID 16144931 DOI: 10.1158/1078-0432.Ccr-04-1223 |
0.327 |
|
| 2005 |
Cao C, Shinohara ET, Niermann KJ, Donnelly EF, Chen X, Hallahan DE, Lu B. Murine double minute 2 as a therapeutic target for radiation sensitization of lung cancer. Molecular Cancer Therapeutics. 4: 1137-45. PMID 16093429 DOI: 10.1158/1535-7163.Mct-04-0327 |
0.35 |
|
| 2005 |
Shinohara ET, Geng L, Tan J, Chen H, Shir Y, Edwards E, Halbrook J, Kesicki EA, Kashishian A, Hallahan DE. DNA-dependent protein kinase is a molecular target for the development of noncytotoxic radiation-sensitizing drugs. Cancer Research. 65: 4987-92. PMID 15958537 DOI: 10.1016/J.Ijrobp.2005.07.246 |
0.404 |
|
| 2005 |
Shinohara ET, Cao C, Niermann K, Mu Y, Zeng F, Hallahan DE, Lu B. Enhanced radiation damage of tumor vasculature by mTOR inhibitors. Oncogene. 24: 5414-22. PMID 15940265 DOI: 10.1038/sj.onc.1208715 |
0.381 |
|
| 2005 |
Lu B, Gonzalez A, Massion P, Shinohara E, Carbone D, Johnson D, Shyr Y, Hallahan D. P-663 Nuclear survivin predicts relapse and poor survival of resectednon-small-cell lung cancer Lung Cancer. 49: S292. DOI: 10.1016/S0169-5002(05)81156-0 |
0.312 |
|
| 2005 |
Kim D, Huamani J, Niermann K, Reyzer M, Yankeelov T, Tumkur S, Geng L, Lee H, Baheza R, Caprioli R, Hallahan D. Radiotherapeutic Schedule Optimization for Targeting Tumor Vasculature: Implications of Non-invasive Physiologic Imaging International Journal of Radiation Oncology*Biology*Physics. 63: S466. DOI: 10.1016/J.Ijrobp.2005.07.793 |
0.312 |
|
| 2005 |
Fu X, Qu S, Hallahan D. Screening of Peptides for Drug Delivery Targeting Irradiated Tumor Vasculature International Journal of Radiation Oncology*Biology*Physics. 63: S464. DOI: 10.1016/J.Ijrobp.2005.07.790 |
0.339 |
|
| 2005 |
Albert J, Shinohara E, Geng L, Tan J, Osusky K, Hallahan D. Pre-Clinical Studies of Gleevec and Radiation in the Treatment of Mouse Models of Glioblastoma International Journal of Radiation Oncology*Biology*Physics. 63: S259-S260. DOI: 10.1016/J.Ijrobp.2005.07.444 |
0.349 |
|
| 2005 |
Willey C, Geng L, Fu A, Osusky K, Hallahan D. Specific Inhibition of p110δ Catalytic Subunit of Phosphatidylinositol 3’-Kinase With IC489666 Radiosensitizes Vascular Endothelium to Provide Improved Tumor Control International Journal of Radiation Oncology*Biology*Physics. 63: S170-S171. DOI: 10.1016/J.Ijrobp.2005.07.293 |
0.327 |
|
| 2005 |
Hariri G, Fu A, Han Z, Hallahan D. Radiation-Inducible Neoantigens for Antibody Targeted Drug Delivery International Journal of Radiation Oncology*Biology*Physics. 63: S169. DOI: 10.1016/J.Ijrobp.2005.07.291 |
0.356 |
|
| 2005 |
Wang H, Feng Z, Chakravarthy B, Powell S, Haffty B, Hallahan D, Xia F. BRCA1 Nuclear Export, a Novel Avenue to Render p53-Deficient Cancer Cell Susceptible to Ionizing Radiation and Cisplatin Induced Cytotoxicity International Journal of Radiation Oncology*Biology*Physics. 63: S120. DOI: 10.1016/J.Ijrobp.2005.07.203 |
0.418 |
|
| 2005 |
Wang H, Osusky K, Yazlovitskaya E, Hallahan D, Xia F. Lithium Protects Hippocampal Neurons From Radiation-Induced Chromosomal Double-Strand Breaks International Journal of Radiation Oncology*Biology*Physics. 63: S85-S86. DOI: 10.1016/J.Ijrobp.2005.07.148 |
0.301 |
|
| 2005 |
Thotala D, Yazlovitskaya E, Edwards E, Osusky K, Hallahan D. GSK-3b Inhibition Helps to Prevent Radiation-Induced Damage in Hippocampal Neurons International Journal of Radiation Oncology*Biology*Physics. 63: S85. DOI: 10.1016/J.Ijrobp.2005.07.147 |
0.327 |
|
| 2004 |
Lu B, Gonzalez A, Massion P, Shyre Y, Carbone D, Hallahan D. Surviving as a therapeutic target and biomarker for non-small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 7153. PMID 28014238 DOI: 10.1200/Jco.2004.22.14_Suppl.7153 |
0.361 |
|
| 2004 |
Geng L, Osusky K, Konjeti S, Fu A, Hallahan D. Radiation-guided drug delivery to tumor blood vessels results in improved tumor growth delay. Journal of Controlled Release : Official Journal of the Controlled Release Society. 99: 369-81. PMID 15451595 DOI: 10.1016/J.Jconrel.2004.07.024 |
0.465 |
|
| 2004 |
Cao C, Mu Y, Hallahan DE, Lu B. XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer. Oncogene. 23: 7047-52. PMID 15258565 DOI: 10.1038/sj.onc.1207929 |
0.311 |
|
| 2004 |
Geng L, Tan J, Himmelfarb E, Schueneman A, Niermann K, Brousal J, Fu A, Cuneo K, Kesicki EA, Treiberg J, Hayflick JS, Hallahan DE. A specific antagonist of the p110delta catalytic component of phosphatidylinositol 3'-kinase, IC486068, enhances radiation-induced tumor vascular destruction. Cancer Research. 64: 4893-9. PMID 15256460 DOI: 10.1158/0008-5472.CAN-03-3955 |
0.366 |
|
| 2004 |
Lu B, Mu Y, Cao C, Zeng F, Schneider S, Tan J, Price J, Chen J, Freeman M, Hallahan DE. Survivin as a therapeutic target for radiation sensitization in lung cancer. Cancer Research. 64: 2840-5. PMID 15087401 DOI: 10.1158/0008-5472.CAN-03-3547 |
0.363 |
|
| 2004 |
Lu B, Gonzalez A, Massion P, Shyr Y, Chen C, Li M, Freyer A, Olson S, Hallahan D. Nuclear staining of survivin as a biomarker for non-small-cell lung cancer International Journal of Radiation Oncology*Biology*Physics. 60: S528. DOI: 10.1016/J.Ijrobp.2004.07.483 |
0.31 |
|
| 2004 |
Stacy D, Massion P, Freeman M, Ely K, Shyr Y, Hallahan D. NRF-2 and thioredoxin-1 staining of a head and neck tissue tumor microarray International Journal of Radiation Oncology*Biology*Physics. 60: S524. DOI: 10.1016/J.Ijrobp.2004.07.476 |
0.314 |
|
| 2004 |
Cao C, Mu Y, Hallahan D, Lu B. Radiation sensitization of lung cancer through inhibition of survivin and XIAP International Journal of Radiation Oncology*Biology*Physics. 60: S365. DOI: 10.1016/J.Ijrobp.2004.07.211 |
0.386 |
|
| 2004 |
Shinohara E, Geng L, Osusky K, Edwards E, Fu A, Hallahan D. The host component of cancer is a biological target for the development of radiosensitizing compounds in the treatment of cancer International Journal of Radiation Oncology*Biology*Physics. 60: S356. DOI: 10.1016/J.Ijrobp.2004.07.194 |
0.322 |
|
| 2004 |
Mu Y, Cao C, Hallahan D, Lu B. Radiation sensitization of glioma via targeting the mtor cell survival pathway International Journal of Radiation Oncology*Biology*Physics. 60: S353. DOI: 10.1016/J.Ijrobp.2004.07.188 |
0.42 |
|
| 2004 |
Brousal J, Mernaugh R, Qu S, Hallahan D. Single chain antibodies (SCFV) targeted to radiation induced neoantigens International Journal of Radiation Oncology*Biology*Physics. 60: S344-S345. DOI: 10.1016/J.Ijrobp.2004.07.172 |
0.362 |
|
| 2004 |
Kaminski J, Fu A, Niermann K, Hallahan D. Recombinant peptides targeted to the radiation-inducible response in tumor microvasculature International Journal of Radiation Oncology*Biology*Physics. 60: S195-S196. DOI: 10.1016/J.Ijrobp.2004.06.136 |
0.423 |
|
| 2004 |
Tan J, Geng L, Hallahan D. A specific antagonist of the p110-delta catalytic component of PI3 kinase, IC486068, enhances radiation-induced tumor vascular destruction International Journal of Radiation Oncology*Biology*Physics. 60: S195. DOI: 10.1016/J.Ijrobp.2004.06.135 |
0.392 |
|
| 2004 |
Tan J, Osusky K, Hallahan D. PKB/AKT is a molecular target to enhance radiation-induced cytotoxicity within tumor vascular endothelium International Journal of Radiation Oncology*Biology*Physics. 60: S194-S195. DOI: 10.1016/J.Ijrobp.2004.06.134 |
0.474 |
|
| 2004 |
Kim D, Geng L, Niermann K, Lee H, Hallahan D. Pharmacodynamics of tumor response to tyrosine kinase inhibitors of VEGF receptors International Journal of Radiation Oncology*Biology*Physics. 60: S148-S149. DOI: 10.1016/J.Ijrobp.2004.06.059 |
0.334 |
|
| 2003 |
Schueneman AJ, Himmelfarb E, Geng L, Tan J, Donnelly E, Mendel D, McMahon G, Hallahan DE. SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models. Cancer Research. 63: 4009-16. PMID 12873999 |
0.372 |
|
| 2003 |
Hallahan D, Geng L, Qu S, Scarfone C, Giorgio T, Donnelly E, Gao X, Clanton J. Integrin-mediated targeting of drug delivery to irradiated tumor blood vessels. Cancer Cell. 3: 63-74. PMID 12559176 DOI: 10.1016/S1535-6108(02)00238-6 |
0.421 |
|
| 2003 |
Cmelak A, Chak B, Scarfone C, Martin W, Hallahan D. Peptide-guided drug delivery to radiation-induced targets in tumor blood vessels International Journal of Radiation Oncology*Biology*Physics. 57: S317-S318. DOI: 10.1016/S0360-3016(03)01191-X |
0.395 |
|
| 2003 |
Hallahan D, Tan J. Radiation-sensitizing gene therapy targeted to tumor vascular endothelium International Journal of Radiation Oncology*Biology*Physics. 57: S317. DOI: 10.1016/S0360-3016(03)01190-8 |
0.441 |
|
| 2003 |
Geng L, Tan J, Stacy D, Hallahan D. Mechanisms of radiation-induced activation of the PI3K/Akt signal transduction pathway in vascular endothelium International Journal of Radiation Oncology*Biology*Physics. 57: S316. DOI: 10.1016/S0360-3016(03)01188-X |
0.375 |
|
| 2003 |
Schueneman A, Himmelfarb E, Geng L, Donnelly E, McMahon G, Laird D, Choy H, Hallahan D. Tyrosine kinase inhibition prevents tumor regrowth following fractionated irradiation of murine tumor models International Journal of Radiation Oncology*Biology*Physics. 57: S296. DOI: 10.1016/S0360-3016(03)01156-8 |
0.384 |
|
| 2003 |
Stacy D, Brousal J, Reyzer M, Mernaugh R, Caprioli R, Hallahan D. MALDI-TOF mass spectrometry for high-throughput screening of ScFv antibodies targeted to radiation-inducible neoantigens International Journal of Radiation Oncology*Biology*Physics. 57: S259-S260. DOI: 10.1016/S0360-3016(03)01098-8 |
0.336 |
|
| 2002 |
Edwards E, Geng L, Tan J, Onishko H, Donnelly E, Hallahan DE. Phosphatidylinositol 3-kinase/Akt signaling in the response of vascular endothelium to ionizing radiation. Cancer Research. 62: 4671-7. PMID 12183424 |
0.36 |
|
| 2002 |
Geng L, Konjeti S, Onishko H, Hallahan D. Tumor targeted drug delivery directed to radiation-induced cell adhesion molecules in tumor vascular endothelium International Journal of Radiation Oncology*Biology*Physics. 54: 27. DOI: 10.1016/S0360-3016(02)03103-6 |
0.337 |
|
| 2002 |
Stacy D, Qu S, Geng L, Hallahan D. Recombinant bacteriophage peptide library recovered from radiation-inducible targets in tumor microvasculature International Journal of Radiation Oncology*Biology*Physics. 54: 25-26. DOI: 10.1016/S0360-3016(02)03100-0 |
0.422 |
|
| 2000 |
Chen A, Scruggs P, Riou J, Prudhomme M, Hallahan D. DNA topoisomerase I (TOP1)-targeted indolocarbazole (INDO) derivatives enhance radiation cytotoxicity in mammalian cells International Journal of Radiation Oncology*Biology*Physics. 48: 162-163. DOI: 10.1016/S0360-3016(00)80119-4 |
0.39 |
|
| 1999 |
Sierra-Rivera E, Teng M, Mernaugh R, Hale N, Chaurand P, Caprioli R, Wang X, Hallahan D. 2015 Proteometric analysis of endothelium to ionizing radiation by use of mass spectrometry and phage library International Journal of Radiation Oncology*Biology*Physics. 45: 286. DOI: 10.1016/S0360-3016(99)90285-7 |
0.311 |
|
| 1996 |
Song PY, Sibley GS, Advani S, Hallahan D, Hyland J, Kufe DW, Chou J, Roizman B, Weichselbaum RR. 137 Enhanced tumor control of human glioblastoma multiforme xenografts with the concomitant use of radiotherapy and an attentuated herpes simplex-1 virus (ASTRO Research Fellowship) International Journal of Radiation Oncology*Biology*Physics. 36: 227. DOI: 10.1016/S0360-3016(97)85479-X |
0.341 |
|
| 1996 |
Hallahan D, Kataoka Y, Kuchibotla J, Virudachalam S, Weichselbaum R. 136 Tissue specific promoters improve the localization of radiation-inducible gene expression International Journal of Radiation Oncology*Biology*Physics. 36: 226. DOI: 10.1016/S0360-3016(97)85476-4 |
0.325 |
|
| 1995 |
Hallahan D, Clark ET, Kuchibhoda J, Gewertz BL. 1026 Cellular adhesion molecules on endothelial cells participate in radiation-mediated inflammation International Journal of Radiation Oncology*Biology*Physics. 32: 236. DOI: 10.1016/0360-3016(95)97851-Q |
0.358 |
|
| 1995 |
Weichselbaum R, Mauceri HJ, Seung LP, Hellman S, Kufe D, Hallahan D. 66 Delivery of radiation inducible gene therapy using the replication deficient adenovirus type 5 International Journal of Radiation Oncology*Biology*Physics. 32: 174. DOI: 10.1016/0360-3016(95)97731-F |
0.349 |
|
| 1994 |
Hallahan DE, Virudachalam S, Kuchibhotla J, Kufe DW, Weichselbaum RR. Membrane-derived second messenger regulates x-ray-mediated tumor necrosis factor alpha gene induction. Proceedings of the National Academy of Sciences of the United States of America. 91: 4897-901. PMID 8197153 DOI: 10.1073/pnas.91.11.4897 |
0.323 |
|
| 1994 |
Hallahan DE, Virudachalam S, Kufe DW, Weichselbaum RR. Ketoconazole attenuates radiation-induction of tumor necrosis factor. International Journal of Radiation Oncology, Biology, Physics. 29: 777-80. PMID 8040024 DOI: 10.1016/0360-3016(94)90566-5 |
0.332 |
|
| 1994 |
Weichselbaum RR, Hallahan D, Beckett M, Mauceri HJ, Lee H, Sukhatme V, Kufe D. Radiation targeting of gene therapy is preferentially cytotoxic to tumor cells International Journal of Radiation Oncology*Biology*Physics. 30: 183. DOI: 10.1016/0360-3016(94)90678-5 |
0.454 |
|
| 1992 |
Hallahan DE, Virudachalam S, Schwartz JL, Panje N, Mustafi R, Weichselbaum RR. Inhibition of Protein Kinases Sensitizes Human Tumor Cells to Ionizing Radiation Radiation Research. 129: 345. DOI: 10.2307/3578035 |
0.324 |
|
| Show low-probability matches. |